About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Internal Medicine 3 and Institute for Clinical Immunology
›
top-articles
Department of Internal Medicine 3 and Institute for Clinical Immunology
74
(top 1%)
papers
4.7K
(top 1%)
citations
37
(top 1%)
h
-index
66
(top 1%)
g
-index
74
all documents
4.9K
doc citations
1.2K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Nature Communications
2012
649
2
Treg cells suppress osteoclast formation: A new link between the immune system and bone
Arthritis and Rheumatism
2007
317
3
12/15-Lipoxygenase Orchestrates the Clearance of Apoptotic Cells and Maintains Immunologic Tolerance
Immunity
2012
204
4
Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints
Annals of the Rheumatic Diseases
2010
198
5
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
Annals of the Rheumatic Diseases
2010
183
6
Dual inhibition of c‐abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
FASEB Journal
2008
179
7
IgG4 immune response in Churg–Strauss syndrome
Annals of the Rheumatic Diseases
2012
171
8
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Annals of the Rheumatic Diseases
2016
154
9
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis
Annals of the Rheumatic Diseases
2017
149
10
Pathways for Bone Loss in Inflammatory Disease
Current Osteoporosis Reports
2012
148
11
12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis
Journal of Immunology
2009
138
12
Churg–Strauss Syndrome in Childhood: A Systematic Literature Review and Clinical Comparison with Adult Patients
Seminars in Arthritis and Rheumatism
2009
124
13
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis
Annals of the Rheumatic Diseases
2011
121
14
Src kinases in systemic sclerosis: Central roles in fibroblast activation and in skin fibrosis
Arthritis and Rheumatism
2008
111
15
Osteoimmunology in rheumatic diseases
Arthritis Research and Therapy
2009
100
16
Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis
Arthritis Research and Therapy
2009
99
17
Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity
Rheumatology
2008
98
18
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Annals of the Rheumatic Diseases
2013
93
19
Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling
Annals of the Rheumatic Diseases
2015
92
20
Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints
Annals of the Rheumatic Diseases
2008
83
21
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study
Rheumatology
2011
78
22
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Annals of the Rheumatic Diseases
2014
78
23
Tophus resolution with pegloticase: a prospective dual-energy CT study
RMD Open
2015
71
24
Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis
Rheumatology
2009
70
25
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
Annals of the Rheumatic Diseases
2013
69
26
12/15-Lipoxygenase during the regulation of inflammation, immunity, and self-tolerance
Journal of Molecular Medicine
2012
63
27
A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses
Annals of the Rheumatic Diseases
2014
62
28
High frequency of autoantibody‐secreting cells and long‐lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice
European Journal of Immunology
2011
59
29
Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNFα single-chain Fv antibody (ESBA105) designed for local therapeutic use
Annals of the Rheumatic Diseases
2010
57
30
Synovial immunopathology in haemochromatosis arthropathy
Annals of the Rheumatic Diseases
2010
55
31
Why does the gout attack stop? A roadmap for the immune pathogenesis of gout
RMD Open
2015
53
32
High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission
Annals of the Rheumatic Diseases
2015
49
33
Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis
Annals of the Rheumatic Diseases
2015
45
34
Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients—A longitudinal analysis
Seminars in Arthritis and Rheumatism
2017
45
35
Anti IL‐17A therapy inhibits bone loss in TNF‐α‐mediated murine arthritis by modulation of the T‐cell balance
European Journal of Immunology
2012
42
36
Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: From Animal Models to Clinical Trials
Current Rheumatology Reports
2011
41
37
Joint remodelling in inflammatory disease
Annals of the Rheumatic Diseases
2007
38
38
Measuring Pain and Efficacy of Pain Treatment in Inflammatory Arthritis: A Systematic Literature Review
Journal of rheumatology Supplement, The
2012
37
39
Structural Bone Changes in pondyloarthritis: Mechanisms Clinical Impact and Therapeutic Considerations
American Journal of the Medical Sciences
2011
33
40
Pathophysiology of Spondyloarthritis
Current Rheumatology Reports
2011
32
41
Pomalidomide is effective for prevention and treatment of experimental skin fibrosis
Annals of the Rheumatic Diseases
2012
31
42
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research
Annals of the Rheumatic Diseases
2011
30
43
Targeting of
NADPH
oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis
Experimental Dermatology
2017
30
44
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
Annals of the Rheumatic Diseases
2015
28
45
There is a need for new systemic sclerosis subset criteria. A content analytic approach
Scandinavian Journal of Rheumatology
2018
28
46
Novel targets in bone and cartilage
Best Practice and Research in Clinical Rheumatology
2010
27
47
Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling
Annals of the Rheumatic Diseases
2014
26
48
Idiopathic hand osteoarthritis vs haemochromatosis arthropathy--a clinical, functional and radiographic study
Rheumatology
2013
25
49
Morphogen Pathways in Systemic Sclerosis
Current Rheumatology Reports
2013
23
50
Multilayered drug delivery coatings composed of daidzein-loaded PHBV microspheres embedded in a biodegradable polymer matrix by electrophoretic deposition
Journal of Materials Chemistry B
2016
20
site/software ©
exaly
; All materials licenced under
CC by-SA
.